Ubiquitination of RPS27A/eS31 is induced by conditions that cause ribosome stalling including amino acid starvation.

(A) Structural models of the human 80S ribosome (left) and of the respective 40S subunit (right) (PDB ID: 6QZP, (Natchiar et al, 2017)). Ribosomal protein RPS27A/eS31 (red) as well as its K113 (yellow) are indicated. 80S is shown from the P-stalk side, 60S subunit (rRNA in dark grey and proteins in teal) and 40S subunit (rRNA in light grey and proteins in blue) are indicated. On the right, 40S is shown from the subunit interface side. Positions of A-, P-, and E-sites as well as major structural elements of the 40S are indicated (B, body; Be, beak; H, head; LF, left foot; RF, right foot; Sh, shoulder). (B) Induction of RPS27A/eS31 ubiquitination by diverse ribosome-stalling compounds. HeLa WT and USP16 KO cells were cultivated in the absence or presence of the following drugs: 0.19 µM anisomycin (30 min), 1.8 µM emetine (30 min), 0.5 µM didemnin B (30 min, 0.25 µg/ml MMS (60 min). Cell extracts were analysed by immunoblotting with the indicated antibodies. (C, D) Quantification of levels of ubiquitinated RPS27A/eS31 in HeLa WT C) and USP16 KO (D) lysates from (B), expressed as the ratio between ubi-RPS27A/eS31 and total RPS27A/eS31 (ubi-RPS27A/eS31 + unmodified RPS27A/eS31) and normalized to samples from untreated cells (N ≥ 4, mean ± SD, one-way ANOVA and post hoc Dunnett’s test; p-values are indicated). (E) Amino acid starvation enhances RPS27A/eS31 ubiquitination. HeLa WT and USP16 KO cells were grown for 6 h in control conditions (Ctrl, no starvation), or in the absence of arginine (-Arg), lysine (-Lys) or both (-Arg-Lys). Cell extracts were analysed by immunoblotting with the indicated antibodies. (F, G) Quantification of levels of ubiquitinated RPS27A/eS31 in HeLa WT (F) and USP16 KO (G) lysates from (E), expressed as the ratio between ubi-RPS27A/eS31 and total RPS27A/eS31 (ubi-RPS27A/eS31 + unmodified RPS27A/eS31) and normalized to samples from non-starved cells (N = 6, mean ± SD, one-way ANOVA and post hoc Dunnett’s test, p-values are indicated.

Ubiquitination of RPS27A/eS31 depends on RNF25.

(A) Analysis of RPS27A/eS31 ubiquitination in HeLa USP16 KO cells upon deletion of RNF25. The RNF25 gene was deleted from USP16 KO cells by CRISPR/Cas9. The parental USP16 KO cells and two clones of USP16/RNF25 double knockout (DKO) cells were cultivated for 6 h in the presence (+) or absence (-) of arginine and lysine. Cell extracts were analysed by immunoblotting with the indicated antibodies. (B) Quantification of levels of ubiquitinated RPS27A/eS31 in cell lysates from (A), expressed as the ratio between ubi-RPS27A/eS31 and total RPS27A/eS31 (ubi-RPS27A/eS31 + unmodified RPS27A/eS31) and normalized to samples from non-starved parental USP16 KO cells (N = 3, mean ± SD, one-way ANOVA and post hoc Tukey’s test, p-values are indicated).

Ubiquitination of RPS27A/eS31 depends on GCN1 but not on EDF1 or ZAKα.

(A) Schematic depiction of various sensors that recognize collided ribosomes in three major quality control pathways: ribosome-associated quality control (RQC), integrated stress response (ISR) and ribotoxic stress response (RSR). (B) Analysis of RPS27A/eS31 ubiquitination in HeLa USP16 KO cells upon depletion of GCN1, EDF1 or ZAKα. USP16 KO cells were treated for two times 48 h with siPOOLs (control or targeting the mRNAs of GCN1, EDF1 or ZAKα). Prior to harvesting, cells were cultivated for 4 h in the absence (-) or presence (+) of 50 nM ternatin. Cell extracts were analysed by immunoblotting with the indicated antibodies. (C) Quantification of levels of ubiquitinated RPS27A/eS31 in cell lysates from (B), expressed as the ratio between ubi-RPS27A/eS31 and total RPS27A/eS31 (ubi-RPS27A/eS31 + unmodified RPS27A/eS31) and normalized to samples from untreated control cells (N ≥ 4, mean ± SD, one-way ANOVA and post hoc Tukey’s test, p-values are indicated). (D) Validation of knockdown experiments from (B). The efficiency of downregulation was analysed by immunoblotting of cell extracts with the indicated antibodies. (E) Analysis of RPS27A/eS31 ubiquitination in HeLa USP16 KO cells upon deletion of GCN1. The GCN1 gene was deleted from USP16 KO cells by CRISPR/Cas9. The parental USP16 KO cells and two clones of USP16/GCN1 DKO cells were cultivated for 6 h in the presence (+) or absence (-) of arginine and lysine. Cell extracts were analysed by immunoblotting with the indicated antibodies. (F) Quantification of levels of ubiquitinated RPS27A/eS31 in cell lysates from (E), expressed as the ratio between ubi-RPS27A/eS31 and total RPS27A/eS31 (ubi-RPS27A/eS31 + unmodified RPS27A/eS31) and normalized to samples from non-starved parental USP16 KO cells (N = 4, mean ± SD, one-way ANOVA and post hoc Tukey’s test, p-values are indicated).

Ubiquitination of RPS27A/eS31 is needed to support translation.

(A) Analysis of polysome profiles upon RNF25 knockdown. RNF25 was depleted from HeLa cells by treatment with siPOOLs for 72 h. Cell extracts were separated by sedimentation in 10%-50% sucrose density gradients and profiles were visualized at 260 nm. (B) Quantification of polysome/monosome (P/M) area ratios in profiles from (A), normalized to control profiles (N = 4, mean ± SD, unpaired two-tailed Student’s t-test, p-value = 0.0002). (C) Validation of knockdown experiments from (A). The efficiency of downregulation was analysed by immunoblotting of cell extracts with the indicated antibodies. (D) Analysis of polysome profiles upon inactivation of the RNF25 pathway. Cell extracts from parental HeLa WT cells or gene-edited RPS27A K113R cells were separated by sedimentation in 10%-50% sucrose density gradients and profiles were visualized at 260 nm. (E) Quantification of polysome/monosome (P/M) area ratios in profiles from (D), normalized to WT profiles (N = 7, mean ± SD, one-way ANOVA and post hoc Dunnett’s test, p-values are indicated). (F) Analysis of polysome profiles of HeLa WT and RPS27A K113R cells upon ISRIB treatment. Parental HeLa WT cells or gene-edited RPS27A K113R cells were treated with 1.1 µM ISRIB for 6 h. Cell extracts were separated by sedimentation in 10%-50% sucrose density gradients and profiles were visualized at 260 nm. (G) Quantification of polysome/monosome (P/M) area ratios in profiles from (F), normalized to WT profiles (N = 5, mean ± SD, one-way ANOVA and post hoc Dunnett’s test, p-values are indicated).

Level of ubiquitinated RPS27A/eS31 increases in the absence of GCN2

(A) Analysis of RPS27A/eS31 ubiquitination in HeLa USP16 KO cells upon deletion of GCN2. The GCN2 gene was deleted from USP16 KO cells by CRISPR/Cas9. The parental USP16 KO cells and two clones of USP16/GCN2 double knockout (DKO) cells were cultivated for 6 h in the presence (+) or absence (-) of arginine and lysine. Cell extracts were analysed by immunoblotting with the indicated antibodies. (B) Quantification of levels of ubiquitinated RPS27A/eS31 in cell lysates from (A), expressed as the ratio between ubi-RPS27A/eS31 and total RPS27A/eS31 (ubi-RPS27A/eS31 + unmodified RPS27A/eS31) and normalized to samples from non-starved parental USP16 KO cells (N = 5, mean ± SD, one-way ANOVA and post hoc Tukey’s test, p-values are indicated). (C) Sequence alignment of RWD domains of RNF25 (aa residues 18-128) and GCN2 (aa residues 25-137). Sequences were visualised in Jalview and aligned with Clustal W. Residues predicted by AlphaFold 3 web server to interact with RWDBD domain of GCN1 are indicated with rectangles. Residues are colored according to the Clustal X color scheme: blue – hydrophobic, red – positive charge, magenta – negative charge, green – polar, orange – glycine, yellow – proline, cyan – aromatic. (D) Prediction of interaction between RWDBD domain of GCN1 and RWD domains of RNF25 and GCN1 using AlphaFold 3. Protein domains as well as positions of respective residues used for the modelling are indicated. Respective pTM and ipTM scores show high-quality predictions (> 0.8) for both the overall protein structure (pTM) and the protein-protein complex (ipTM). Indicated polar contacts were analysed with PyMol. (E) Analysis of RPS27A/eS31 ubiquitination in HeLa USP16 KO cells upon transient overexpression of the indicated GCN2 fragments containing an N-terminally StStHA-tagged RWD domain (aa 1-145). The effect of WT and 3K mutant (D37K, E125K and E136K substitutions) RWD domains was compared to control conditions (transfection of empty vector). Cell extracts were analysed by immunoblotting with the indicated antibodies. (F) Quantification of levels of ubiquitinated RPS27A/eS31 in cell lysates from (E), expressed as the ratio between ubi-RPS27A/eS31 and total RPS27A/eS31 (ubi-RPS27A/eS31 + unmodified RPS27A/eS31) and normalized to control samples (N = 6, mean ± SD, one-way ANOVA and post hoc Tukey’s test, p-values are indicated).

Model for the activation of the RNF25 pathway.

Upon conditions that induce ribosome stalling (such as low doses of translation inhibitors, mRNA damage or amino acid starvation) as well as upon natural transient stalling events, collided ribosomes are recognized by GCN1. Following GCN1 binding, RNF25 is recruited onto ribosomes through the interaction between its RWD domain and the RWDBD domain of GCN1, resulting in the ubiquitination of RPS27A/eS31 and subsequent resolution of stalled ribosomes. Alternatively, the DRG2/RWDD1 complex can also interact with GCN1 and engage in resolution of stalled ribosomes that have no protein factor in the A-site factor binding region, but a tRNA bound in the A-site. With an increased number of collisions or more persistent collisions, GCN1 recruits GCN2 through interaction with its RWD domain, which induces activation of the ISR pathway and inhibition of translation.